| Literature DB >> 35515416 |
Ru Li1, Zhi-Li Li1, Ya-Ping Chen1, Wei-Quan Bu2, Wen-Bo Ding2, Bing Yang2, Chun-Fei Wang2, Liang Ma2, Xiao-Bin Jia1, Liang Feng1.
Abstract
The purpose of this study is to explore the intrinsic reasons for the superiority of the salt-made geoherb Alisma orientale via comparing the content of various components of the salt-made geoherb Alisma orientale. The effects of "diuresis and diffusing dampness" using salt-made Alisma orientale from seven different origins were investigated through pharmacodynamic experiments in vivo and in vitro. The results indicated that salt-made Alisma orientale from different origins had diuretic efficacy; this was demonstrated by the significant increase in the volume of rat urine, the concentration of Na+, K+, and Cl- in the urine, and the significant decrease in the levels of AQP-2 in rat renal medulla and HK-2 cells. It was also revealed that the diuretic effect of salt-made Alisma orientale from Fujian Province is stronger than those from other provinces. Moreover, the main components and their proportions in the salt-made Alisma orientale samples were further analyzed via principal component analysis. The results showed that alisol A 24-acetate, alisol B, and 23-acetyl alisol B are the main components of salt-made Alisma orientale, and the optimal structural ratio of alisol A 24-acetate, alisol B, and 23-acetyl alisol B was found to be 5.38 : 14.34 : 11.31 via optimizing the ratios of the three main components. It is worth noting that the optimal ratio of the three main components after optimization is the closest to the ratio of the three main components in salt-made Alisma orientale from Fujian Province. This paper reveals the "mystery" of the content ratio of the main active components and its effect on the efficacy, and showed that the proportional relationship between the content of multiple components is the key to their interactions. Therefore, this method of evaluating the quality of salt-made Alisma orientale is obviously reliable, and this study lays the foundations for quality evaluation of salt-made Alisma orientale and other herb slices. This journal is © The Royal Society of Chemistry.Entities:
Year: 2020 PMID: 35515416 PMCID: PMC9057405 DOI: 10.1039/c9ra08469j
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 4.036
Information about salt-made Alisma orientale from each production area
| Origin | Company |
|---|---|
| Fujian Province | Anhui Jingquan Group Chinese Herbal Medicine Co., Ltd |
| Sichuan Province | Chengdu Zhongchuan Pharmaceutical Co., Ltd |
| Jiangxi Province | Jiangxi Heye Zexie Kunshan Sales Co., Ltd |
| Guangxi Province | Zhejiang Yingte Chinese Herbal Pieces Co., Ltd |
| Hubei Province | Hubei Yuancheng Saichuang Technology Co., Ltd |
| Henan Province | Nanyang Zhang Zhongjing Chinese Herbal Medicine Development Co., Ltd |
| Hebei Province | Hebei Dongsheng Yinghua Pharmaceutical Co., Ltd |
Total terpenoid component compositionsa
| 24A : B : 23B | B : 23B : 24A | 23B : 24A : B |
|---|---|---|
| (I-1) 2.99 : 14.34 : 11.43 | (II-1) 14.34 : 11.31 : 11.48 | (III-1) 11.31 : 2.99 : 14.25 |
| (I-2) 2.99 : 14.34 : 8.08 | (II-2) 14.34 : 11.31 : 5.38 | (III-2) 11.31 : 2.99 : 9.06 |
| (I-3) 2.99 : 14.34 : 6.01 | (II-3) 14.34 : 11.31 : 2.64 | (III-3) 11.31 : 2.99 : 8.84 |
| (I-4) 2.99 : 14.34 : 5.23 | (II-4) 14.34 : 11.31 : 2.20 | (III-4) 11.31 : 2.99 : 7.85 |
“24A”, “B”, and “23B” respectively represent “alisol A 24-acetate”, “alisol B”, and “23-acetyl alisol B”.
Determination of biochemical criteria in rats after being treated with Alisma orientale from different provincesa
| Normal adult required quantity (g d−1) | Dosage in rats relative to crude drug (g kg−1 d−1) | Urine volume (mL) | Na+ (mmol L−1) | K+ (mmol L−1) | Cl− (mmol L−1) | |
|---|---|---|---|---|---|---|
| Blank control group | — | — | 4.70 ± 0.25 | 51.48 ± 23.09 | 38.96 ± 0.75 | 109.83 ± 13.95 |
| Furosemide positive control group | — | 0.02 | 20.00 ± 1.06** | 174.95 ± 38.79** | 58.49 ± 0.47** | 207.55 ± 7.25** |
| Fujian | 45 | 4.0 | 13.80 ± 0.25** | 94.74 ± 25.43** | 57.08 ± 2.81** | 194.35 ± 16.74** |
| Fujian | 10 | 0.9 | 6.20 ± 0.14* | 79.15 ± 39.73* | 47.41 ± 3.94* | 158.95 ± 27.68* |
| Jiangxi | 45 | 4.0 | 12.90 ± 0.10** | 95.12 ± 27.62** | 51.59 ± 1.40** | 183.83 ± 26.62** |
| Jiangxi | 10 | 0.9 | 6.10 ± 0.11* | 67.34 ± 15.81* | 43.00 ± 0.85* | 143.79 ± 11.39* |
| Sichuan | 45 | 4.0 | 12.80 ± 0.50** | 94.77 ± 24.76** | 49.44 ± 0.63** | 189.86 ± 6.69** |
| Sichuan | 10 | 0.9 | 6.00 ± 0.05* | 57.29 ± 22.72* | 41.37 ± 1.74* | 141.79 ± 18.24* |
| Guangxi | 45 | 4.0 | 11.20 ± 0.95* | 95.52 ± 10.15* | 56.36 ± 2.92* | 191.75 ± 20.71* |
| Guangxi | 10 | 0.9 | 5.60 ± 0.40* | 71.42 ± 8.45* | 49.90 ± 1.52* | 152.81 ± 16.51* |
| Hubei | 45 | 4.0 | 11.90 ± 0.85* | 90.15 ± 18.65* | 54.13 ± 0.78* | 181.32 ± 9.47* |
| Hubei | 10 | 0.9 | 5.80 ± 0.60* | 67.11 ± 11.89* | 45.36 ± 1.80* | 155.38 ± 14.13* |
| Henan | 45 | 4.0 | 11.7 ± 0.40* | 93.43 ± 22.23* | 53.58 ± 2.55* | 184.11 ± 12.24* |
| Henan | 10 | 0.9 | 5.70 ± 0.15* | 66.30 ± 36.79* | 50.27 ± 1.11* | 127.09 ± 21.80* |
| Hebei | 45 | 4.0 | 10.50 ± 1.20* | 91.60 ± 23.50* | 54.85 ± 2.70* | 180.79 ± 6.25* |
| Hebei | 10 | 0.9 | 5.40 ± 1.13* | 76.30 ± 22.69* | 44.29 ± 2.38* | 124.76 ± 16.68* |
Compared with the blank group, *P < 0.05, **P < 0.01.
Characteristic values and the variance contribution rates
| Component | Initial characteristic value | Extraction sums of squared loadings | ||||
|---|---|---|---|---|---|---|
| Characteristic value | % of variance | Cumulative% | Total | % of variance | Cumulative% | |
| 1 | 3.500 | 87.490 | 87.490 | 3.500 | 87.490 | 87.490 |
| 2 | 0.395 | 9.865 | 97.354 | |||
| 3 | 0.080 | 2.001 | 99.355 | |||
| 4 | 0.026 | 0.645 | 100.000 | |||
Fig. 1The expression and quantitative analysis of AQP-2 in rats: (a) control group; (b) positive group; (c) high dosage of Fujian; (d) low dosage of Fujian; (e) high dosage of Sichuan; (f) low dosage of Sichuan; (g) high dosage of Jiangxi; (h) low dosage of Jiangxi; (i) high dosage of Guangxi; (j) low dosage of Guangxi; (k) high dosage of Hubei; (l) low dosage of Hubei; (m) high dosage of Henan; (n) low dosage of Henan; (o) high dosage of Hebei; and (p) low dosage of Hebei. *P < 0.05, versus control group.
Cell viability relating to different concentrations of Alisma orientale in HK-2 cells (mean ± SD, n = 6)a
| Group | Dosage (g mL−1) | Cell survival rate (%) |
|---|---|---|
| Blank | — | 100 ± 1.15 |
| Alcohol extract of Fujian salt-made | 1.0 × 10−3 | 45.06 ± 1.12* |
| 5.0 × 10−4 | 49.08 ± 1.45* | |
| 2.5 × 10−4 | 56.18 ± 1.28* | |
| 1.25 × 10−4 | 67.30 ± 1.53* | |
| 6.25 × 10−5 | 83.52 ± 1.70* | |
| 3.125 × 10−5 | 95.36 ± 1.54 | |
| 1.5625 × 10−5 | 96.37 ± 1.49 | |
| 7.8125 × 10−6 | 98.33 ± 1.62 | |
| 3.90625 × 10−6 | 99.67 ± 1.31 |
Compared with the blank group, *P < 0.05.
Fig. 2The expression and quantitative analysis of AQP-2 in HK-2 cells. (a) Control group; (b) positive group; (c) high dosage of Fujian; (d) low dosage of Fujian; (e) high dosage of Sichuan; (f) low dosage of Sichuan; (g) high dosage of Jiangxi; (h) low dosage of Jiangxi; (i) high dosage of Guangxi; (j) low dosage of Guangxi; (k) high dosage of Hubei; (l) low dosage of Hubei; (m) high dosage of Henan; (n) low dosage of Henan; (o) high dosage of Hebei; and (p) low dosage of Hebei. *P < 0.05, versus control group.
Fig. 3Comparison of the characteristics of salted Alismatis Rhizoma from different places.
Fig. 4HPLC chromatograms of salted Alismatis Rhizoma samples from different places; these are: Fujian Province, Jiangxi Province, Sichuan Province, Guangxi Province, Hubei Province, Hebei Province, and Henan Province, from front to back.
Peak area comparison of 12 components in salt-made Alisma orientale from different origins
| Peak no. | Fujian | Jiangxi | Sichuan | Guangxi | Hubei | Hebei | Henan |
|---|---|---|---|---|---|---|---|
| 1 | 34.1 | 184.8 | 144.9 | 31.7 | 317.7 | 346.8 | 222.0 |
| 2 | 117.0 | 163.0 | 111.7 | 143.2 | 287.5 | 60.6 | 152.9 |
| 3 | 9.4 | 213.8 | 24.2 | 761.3 | 496.2 | 780.2 | 965.3 |
| 4 | 20.3 | 40.3 | 26.3 | 18.5 | 15.7 | 44.9 | 25.7 |
| 5 | 357.3 | 121.4 | 777.1 | 1433.1 | 695.9 | 151.9 | 659.3 |
| 6 | 687.6 | 160.5 | 516.8 | 58.4 | 921.0 | 1868.5 | 653.5 |
| 7 | 189.4 | 111.8 | 516.8 | 321.5 | 107.5 | 112.1 | 75.2 |
| 8 | 176.4 | 160.5 | 338.8 | 610.2 | 376.4 | 51.8 | 275.0 |
| 9 | 70.9 | 105.9 | 190.4 | 438.6 | 219.1 | 37.8 | 225.1 |
| 10 | 23.0 | 205.3 | 579.1 | 453.0 | 45.6 | 153.0 | 38.1 |
| 11 | 89.2 | 295.6 | 154.4 | 183.0 | 143.9 | 252.7 | 133.2 |
| 12 | 10.6 | 592.9 | 225.8 | 45.6 | 227.9 | 711.2 | 178.5 |
Characteristic values and the variance contribution rates
| Component | Initial characteristic value | Extraction sums of squared loadings | ||||
|---|---|---|---|---|---|---|
| Characteristic value | % of variance | Cumulative% | Total | % of variance | Cumulative% | |
| 1 | 4.864 | 40.533 | 40.533 | 4.864 | 40.533 | 40.533 |
| 2 | 2.831 | 23.589 | 64.122 | 2.831 | 23.589 | 64.122 |
| 3 | 2.078 | 17.315 | 81.437 | 2.078 | 17.315 | 81.437 |
| 4 | 1.103 | 9.192 | 90.629 | 1.103 | 9.192 | 90.629 |
| 5 | 0.682 | 5.679 | 96.308 | |||
| 6 | 0.311 | 2.594 | 98.903 | |||
| 7 | 0.078 | 0.646 | 99.549 | |||
| 8 | 0.054 | 0.451 | 100.000 | |||
| 9 | 4.631 × 10−16 | 3.859 × 10−15 | 100.000 | |||
| 10 | 1.870 × 10−16 | 1.558 × 10−15 | 100.000 | |||
| 11 | 1.970 × 10−17 | 1.641 × 10−16 | 100.000 | |||
| 12 | −2.272 × 10−16 | −1.893 × 10−15 | 100.000 | |||
Relative principal component matrix data
| Component | Principal component | |||
|---|---|---|---|---|
| 1 | 2 | 3 | 4 | |
| X1 | −0.070 | 0.714 | 0.530 | −0.215 |
| X2 | 0.237 | −0.405 | 0.568 | −0.603 |
| X3 | 0.015 | −0.108 | 0.713 | 0.676 |
| X4 | −0.718 | 0.481 | −0.199 | 0.236 |
| X5 | 0.955 | −0.071 | 0.132 | 0.206 |
| X6 | −0.760 | 0.068 | 0.140 | 0.255 |
| X7 | 0.655 | 0.216 | −0.655 | 0.009 |
| X8 | 0.973 | −0.121 | 0.156 | 0.045 |
| X9 | 0.932 | −0.061 | 0.281 | 0.202 |
| X10 | 0.695 | 0.451 | −0.488 | 0.114 |
| X11 | 0.204 | 0.915 | 0.164 | −0.095 |
| X12 | 0.163 | 0.894 | 0.305 | −0.092 |
Composition and structural characteristics of salt-made Alisma orientale
| Origin | Peak area | Structural characteristics (peak area ratio) | ||
|---|---|---|---|---|
| Alisol A 24-acetate | Alisol B | Alisol B 23-acetate | ||
| Fujian | 176.4 | 70.9 | 23.0 | 1 : 0.40 : 0.13 |
| Jiangxi | 160.5 | 105.9 | 205.3 | 1 : 0.66 : 1.28 |
| Sichuan | 338.8 | 190.4 | 579.1 | 1 : 0.56 : 1.71 |
| Guangxi | 610.2 | 438.6 | 453.0 | 1 : 0.72 : 0.74 |
| Hubei | 376.4 | 219.1 | 45.6 | 1 : 0.58 : 0.12 |
| Hebei | 51.8 | 37.7 | 153.0 | 1 : 0.73 : 2.95 |
| Henan | 275.0 | 225.1 | 38.1 | 1 : 0.82 : 0.14 |
Fig. 5The protein expressions of AQP-2 and Kim-1 were determined using western blot. *: P < 0.05, compared with the control group.